Posaconazole for Suspension(Zhejiang Poly Pharma)

泊沙康唑干混悬剂(浙江普利药业)

Report date: 2025/08/20 15:18:48

Base Information

Drug NamePosaconazole for Suspension(Zhejiang Poly Pharma)
Drug Alias NamePosaconazol泼康唑Posaconazolum泊沙抗唑
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsCandidiasis, OralCandidiasisAspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCandidiasis, OralCandidiasisAspergillosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A